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Abstract 
Background: The human body is colonized by millions of bacteria, with the permanent 
colonizers referred to collectively as the microbiome.  The microbiome, microbial by-
products of metabolism affect the human body in numerous ways, providing a protective 
and often symbiotic relationship with the human host.  Nevertheless, through 
environmental fluctuations, individual’s genetic predisposition and/or unknown factors, 
dysbiosis or a state of imbalance may develop, leading to the development of diseases, 
including cancer.  The effects of microbial dysbiosis are largely focused on the 
gastrointestinal system and development of gastric-related disorders. 
Aims: This research review extends the scope of the microbiome’s role outside of the 
gastrointestinal domain, specifically investigating pathways by which the microbiome 
modulates breast cancer risks. 
Method: CINAHL and PubMed databases, journals, and citation indices were searched 
using the keyword “microbiome” in combination with breast cancer, dysbiosis, estrogen, 
immune system, obesity, epigenetics, nursing.	    
Results: The microbiome plays an active role in modulating estrogenic levels, in 
establishing and stimulating the immune system, and contributes to the development of 
obesity affecting breast cancer development through epigenetic dysregulation.  Many 
epigenetic changes are reversible through either pharmacotherapy or through behavioral 
changes, and therefore are amenable to nursing interventions.  Knowledge of the 
microbiome’s systemic effects can shed light on individualized breast cancer prevention 
and treatment care plans, improve dietary guidelines, and bolster the immune system.	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Breast Cancer Background 
It is predicted that 1 out of 8 women will develop invasive breast cancer, the most 
common cancer that affects women.  Greater than two hundred thousand new cases are 
expected to develop this year alone, claiming the lives of more than 40,000 women per 
year, and half a million annually worldwide (Siegel, Miller, & Jemal, 2015; Stewart & 
Wild, 2014). 
The breast is composed of multiple cell types that give rise to at least five breast 
cancer subtypes.  These subtypes are termed: luminal A; luminal B; HER2-enriched; 
normal-like, and basal-like (Rattani & Swift-Scanlan, 2014).  Gene expression refers to 
the process whereby the instructions in DNA are copied to RNA and translated to their 
final protein product.	  	  Not everyone who is genetically pre-disposed to breast cancer 
develops breast cancer, pointing to the role environmental factors play in carcinogenesis.  
Modifiable risk factors in breast cancer development include: parity, breastfeeding, body 
mass index, oral contraceptive use, menopausal hormone therapy use, consumption of 
alcohol, cigarette smoking, and physical activity (Nickels et al., 2013).  These 
environmental risk factors may be modifying an individual’s susceptibility to cancer by 
decreasing genetic expression at the epigenome level (Rattani & Swift-Scanlan, 2014; 
Bardowell et al., 2013). 
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Epigenetics refers to processes by which gene expression and function are altered 
and modified without changing the actual DNA sequence (Aguilera, Fernandez, Munoz, 
& Fraga, 2010).  One epigenetic change, DNA methylation, can lead to alterations that 
influence the way proteins (histones) package DNA.   If the histones that comprise 
chromatin are packaged too tightly, then the DNA is not accessible to being copied to 
mRNA and ultimately gene expression is silenced.  An individual’s epigenome can 
accumulate alterations over a lifetime due to intrinsic (genetic), environmental, and/or 
undetermined factors (Aguilera et al., 2010).  In individuals with breast cancer, tumor 
suppressor genes are often inactivated or deleted through changes in epigenetic regulation 
in response to environmental stimuli (Toland, 2012). 
One frequently overlooked contributor to epigenetic dysregulation that interacts at 
the physiologic and environmental level is the microbiome.  Fluctuations within 
microbial communities of the human body (collectively referred to as the “microbiome”), 
microbial interaction with the human host immune system, and downstream chemical 
changes influenced by bacterial metabolic by-products, may all be involved in pathways 
that can impact epigenetic alterations.  Ultimately, microbiome research may help 
individualize cancer treatments by identifying new therapeutic targets. Of notable interest 
to nursing, is that many epigenetic changes are reversible through either pharmacotherapy 
or through behavioral changes, and therefore are amenable to clinical interventions. For 
example, the microbiome can be influenced by diet and other modifiable exposures, and 
therefore hold promise for improving health outcomes in general, and cancer prevention 
in particular.  
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The Human Microbiome 
The human body is host to more than 10 trillion microbial cells.  In humbling 
contrast, the human genome contains ~20,000 protein-coding genes.  Most of the human 
microbial cells reside in the lumen of the GI tract, but different communities find suitable 
residences in different anatomical sites (Bultman, 2014).  The symbiotic coexistence of 
microbes benefits the human hosts in a number of ways including: carbohydrate 
metabolism, nutrient reclamation from food, absorption of minerals, and breakdown of 
dietary toxins (Shapira, Sultan, Lee, & Taioli, 2013).  In turn, the human gut provides an 
optimal habitat, supplying the bacteria with a steady stream of nutrients, and protecting 
the microbes from nematodes, roundworms and other bacterial adversaries (Bultman, 
2014).  This symbiosis points to a historical process of the microbes’ co-evolution with 
humans, with more and more researchers describing humans as a “supraorganism”--that 
is, a single organism system composed of multiple organisms. 
Therefore, the Human Microbiome Project (HMP) was initiated to better 
understand the complex molecular and environmental impacts of the microbiome on 
human health. The HMP is a worldwide joint scientific venture, designed to gain further 
understanding of microbiome structure and function, by characterizing the microbial 
communities of various body sites and testing correlations between microbiome 
fluctuations over time and its relation to human health.  A clearer picture of variations in 
human microbiota has been accelerated by the use of advanced tools, epidemiological 
studies, whole genome sequencing, gnotobiotic (germ-free) mouse models, next-
generation sequencing, and phylogenetic microarray (Aguilera et al., 2010; Bultman, 
2014; Rajilic-Stojanovic, Heilig, Tims, Zoetendal, & de Vos, 2012). 
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HMP researchers group and classify the human gut microbiota that is composed 
of viruses, fungi, and bacteria (Robinson & Pfeiffer, 2014).  This paper narrows its focus 
on the bacterial role in the microbiome.  Due to diversity and sheer number, finding 
bacterial communities that were consistently similar between individuals, and across 
cultural, national and continental boundaries was thought to be an onerous task.   
However, investigations of the  “core” human microbiome repeatedly find more than 
90% of all bacterial phylogenetic types belong to 2 of the 70 known divisions (phyla) –
Bacteriodetes and Firmicutes (Rajilic-Stojanovic et al., 2012; Turnbaugh et al., 2007). 
Recent findings further indicate environmental fluctuations (including use of antibiotics, 
dietary cleanses and regimes, compositional changes from traveling), may affect the 
abundance, but not necessarily the presence and composition of specific core microbial 
species (Rajilic-Stojanovic et al., 2012). 
A unified classification framework and nomenclature for all bacteria has recently 
been introduced (Yarza et al., 2014).  The lack of standardization up until recently, 
produced disagreement amongst which phylotypes are considered “permanent 
colonizers,” categories that varied depending on the assay method used (Rajilic-
Stojanovic et al., 2012; Shapira et al., 2013).  Using 16S Ribosomal RNA sequencing, 
Shapira et al. lists 7 major phyla that are consistently found amongst children, adults and 
elderly as: Actinobacteria, Bacteriodetes, Verrucomicrobia, Firmicutes, Tenericutes, 
Proteobacteria, and Cyanobacteria (Shapira et al., 2013).  Meanwhile, Rajilic-Stojanovic 
et al. (2012), used human intestinal tract chip (HITChip) comprehensive phylogenetic 
microarray to identify the following core phyla:  Bifidobacterium, Bacteroidetes, 
Faecalibacterium, Blautia, Dorea, and Ruminococcus.  These discrepant findings indicate 
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the need for continued investigation in what constitutes the microbiome core, and the use 
of standard framework for nomenclature/classification (Rajilic-Stojanovic et al., 2012; 
Yarza et al., 2014). 
Conversely, Arumugam et al. (2011) sought to classify the microbiome through a 
higher level of consolidated genomic studies.  Using new “metagenome” derived 
functional biomarkers from four countries’ fecal data and comparing these data with 
1,511 phylogenetic profile reference genomes from around the world, the study proposed 
that microbial species can be classified into one of three distinct groups or enterotypes 
that is neither nation nor continent specific. Though there were methodological 
limitations, including the fact that fecal samples are not representative of the entire gut 
microbiome, the study suggests that the metagenomic classification of three biomarker 
molecules (two of which are ATP complexes that corresponds with the body’s Body 
Mass Index) may be more important than phylogenetic differences (Arumugam et al., 
2011).  Despite varied classification methods, there is growing support of a “core” 
microbial community across individuals that remain fairly constant and invariable over 
long periods of time (Rajilic-Stojanovic et al., 2012).  Therefore, it is recommended that 
testing associations of specific microbiota compositions with environmental exposures 
and/or disease risk should be limited to the numerically most dominant phylotypes 
(Durban, Abellan, Jimenez-Hernandez, Latorre, & Moya, 2012). 
Applications of knowledge gained from studying microbial communities have 
been largely focused on obesity, gastrointestinal cancer development, and other gastric 
problems.  More recently, the scope of study has expanded into other areas, including the 
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microbiome’s role in breast carcinogenesis or in treatment of breast cancers.  
 
Establishment of Ecosystem and Dysbiosis 
 
The bacterial communities in the intestine are inherited at birth through the birth 
canal and skin to mouth contact.  The bacteria first to arrive establish numerical 
dominance.  Subsequently, they can either cooperate with newcomers or exclude 
competitors (Durban et al., 2012).  In addition to the first-comer’s established presence, 
however, other factors play a role in the composition of an individual’s microbiome 
ecosystem, including variations relative to genetic conditions, age, medication, and diet.  
Such changes may ultimately lead to unique pH, temperature, or secretions, offering 
microenvironments favorable to select bacterial communities (Shapira et al., 2013).  
When outside influences such as disease, medications, and altered diet disturb the 
established ecosystem, the result is described as a state of dysbiosis.  Dysbiosis leads to 
abnormalities of the host immune system, continued inflammation, leaves the host 
vulnerable to pathogens, and encourages rapid replication of pathogenic bacteria that 
further propagate the continued disequilibrium (Arthur et al., 2012; Shapira et al., 2013; 
Sheflin, Whitney, & Weir, 2014).  
 
Microbiome Dysbiosis and Increased Estrogenic Burden  
In the case of breast cancer, dysbiosis is implicated in increased production of 
metabolites that raise circulating levels of estrogen.  In the 70s, a study proposed that 
Lecithinase-negative clostridia have the ability to stimulate production of estradiol, 
estrone, and 17-methoxy-extradiol from androstenedione (precursor of male and female 
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sex hormones).  These are carcinogens that act on mammary tissue or promote tumor 
growth (Hill, Goddard, & Williams, 1971).  Since then, more evidence for the role of 
estrogen in tumor formation has been uncovered.  Studies of postmenopausal women 
have consistently produced results indicating that higher levels of estradiol, estrone, and 
estrone sulfate circulating in the body are positively correlated with an increased risk of 
breast cancer (Fuhrman et al., 2012).  In fact, approximately 80% of breast cancers 
express the estrogen receptor, making estrogen receptor (ER) positive breast cancer the 
most prevalent breast cancer type (Al-Hussaini, Subramanyam, Reedijk, & Sridhar, 2011; 
Cancer Genome Atlas Network, 2012).  
Recently, linkages between circulating levels of estrogen, breast cancer risk, and 
microbial activity in the human gut have also been described.  Fuhrman et. al (2012) 
found that higher circulating levels of estrogen may depend on individual’s microbial 
composition.   Drawing on data from the multi-center Prostate, Lung, Colorectal and 
Ovarian Cancer Screening Trial, which followed 39,116 female participants, ages 55-74 
year in a period of 8 years, the authors concluded that nearly all estrogen, estrogen 
metabolites, and particularly the serum concentration of unconjugated estradiol, is 
associated with increased risk of breast cancer (Fuhrman et al., 2012).  Estrogen 
circulates bound to protein or free in the blood and is deactivated by the liver and 
transported to the intestinal lumen as bile acids.  Individuals that have bacterial colonies 
favorable to the growth of Proteobacteria species (E.coli, Klebsiella, Enterobacter, 
Citrobacter), that outcompete commensal bacteria such as Firmicutes and Bacteriodetes, 
have increased estrogenic burden.  E.coli has been shown to produce beta-glucuronidase 
that acts to deconjugate estrogen in the intestinal lumen, recycling the estrogen back into 
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the bloodstream rather than being secreted in feces or urine (Plottel & Blaser, 2011; 
Shapira et al., 2013). 
 Interestingly, another study found that women with higher urinary excretion of 
parent estrogens are at lower risk for breast cancer, thus supporting the hypothesis that 
once circulating estrogens are removed, breast cancer risk decreases (Eliassen et al., 
2012).  Subsequently, a different follow-up study collected both urine and fecal samples 
from 60 postmenopausal subjects and found urinary excretion of estrogen was linked to 
bacterial activity.  Their findings suggest that women with a more diverse gut 
microbiome demonstrated an elevated urinary [excretion] ratio of hydroxylated estrogen 
metabolites to parent estrogen (Fuhrman et al., 2012). 
 
Microbiome and the Immune System 
 
The microbiome also plays an active role in enhancing or undermining the host 
immune system, contributing to tumorigenesis and metastasis, that holds promise for 
potential cancer prevention and treatment strategies.  The microbiome modulates and 
contributes to chronic inflammation, helps to maintain gut epithelial cells, influences the 
number of circulating neutrophils, and can enhance or suppress the immune system in 
both human and animal models (Shapira et al., 2013; Turnbaugh et al., 2007). 
All bacteria, including bacteria with established beneficial roles, have the 
potential to become pathogens.  In fact, up to 20% of all cancers worldwide are related to 
microbial infection and subsequent inflammation (Elinav et al., 2013).  Chronic 
inflammation, a dysregulated protective mechanism of continuous tissue repair and 
growth response, is firmly established as a risk factor for tumorigenesis.  Chronic 
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inflammatory processes produce toxins and free radicals that damage host DNA, and can 
accelerate the development of mammary tumors (Caygill, 2012; Elinav et al., 2013; 
Iyengar, Morris, Hudis, & Dannenberg, 2013; Rakoff-Nahoum, 2007; Rao et al., 2006; 
Schwabe & Jobin, 2013). 
Additionally, specific bacterial interactions with the immune cells can result in 
structural differences of the immune system.  The bacterial role can be seen in a 
neonate’s Peyer’s patches that function to stimulate the B cells and T cells, isolated 
lymphoid follicles (IFLs) and mesenteric lymph nodes (MLN).  The development of 
these immune sentinels is spurred by microbial colonizers (Maynard, Elson, Hatton, & 
Weaver, 2012).  In contrast, gnotobiotic or germ free rodents, have considerably 
decreased neutrophil number and function, and significantly smaller or reduced Peyer’s 
patches, spleen and mesenteric lymph nodes (MSN) – all of which were attributed to the 
absence of microbiota (Reading & Kasper, 2011; Shapira et al., 2013). In fact, the 
introduction of “as little as” one commensal bacterial species, can lead to better 
immunity, reduces the rate and susceptibility to infection and chronic inflammation 
(Reading & Kasper, 2011).   
See Table 1 for Bacterial Role in the Immune System.  
 
Dysbiosis of the Microbiome, Obesity and Carcinogenesis  
 
The importance of the microbiome in breast carcinogenesis and breast cancer 
prognosis is especially evident when looking into the growing trends in obesity.  Obesity 
is a risk factor for the initiation of breast cancer, and is associated with larger tumors, 
poor treatment prognosis, metastasis, and cancer recurrence (Iyengar et al., 2013; Protani, 
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Coory, & Martin, 2010).   A study comparing obese individuals with those classified as 
overweight found that obesity, along with increased hip to waist ratio, doubles the breast 
cancer incidence in both pre-and post-menopausal women (Amadou et al., 2013; Biglia et 
al., 2013; Simpson & Brown, 2013).   
 
Mechanism linking Obesity to Breast Cancer  
Obesity is not only associated with metabolic dysfunction such as Type 2 
Diabetes, insulin resistance, vascular disorders and kidney problems, but is also linked to 
breast cancer by several metabolic pathways.  Adipose tissue is now recognized as an 
endocrine organ. Adipose cells have estrogen receptors, and produce leptin, that 
stimulates the body’s metabolic function as well as other important hormonal functions 
(Galic, Oakhill & Steinberg, 2010).  In adipose tissue, low grade-inflammation and 
dysregulated metabolism increase aromatase expression, an enzyme responsible for the 
synthesis of estrogen (Simpson & Brown, 2013).  Observed histologically in actual tumor 
sites, increased aromatase enzyme contributes to chronic inflammation.   Adipocytes of 
breast tissue are filled with lipids and saturated fatty acids that can circulate in the blood 
stream, and cause activation of inflammatory complexes such as tumor necrotic factor 
(TNF)-α.  In addition, adipocyte tissues are often hypoxic, with few blood vessels that 
recruit activated macrophages (M1) into the surrounding fat cells.  Infiltrated with M1, 
adipose cells releases cytokines and TNF-α, creating a chronic state of low-grade 
inflammation and increasing breast cancer risk (Harford, Reynolds, McGillicuddy, & 
Roche, 2011; Olefsky & Glass, 2010; Simpson & Brown, 2013; Galic, Oakhill & 
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Steinberg, 2010).  
 
Microbiome’s Role in Obesity  
Obesity is an epidemic in the US and worldwide.   Obesity statistics reveal more 
than a third of Americans are currently obese, with as much as 65% of the American 
population expected to be obese by 2030 (Iyengar et al., 2013).  Considering this rising 
trend, the negative health effects, and the cost of obesity-related treatments, uncovering 
the microbiome’s role in obesity has generated a lot of excitement.    
When comparing obese to lean microbiomes between twins, obesity is associated 
with reduced bacterial diversity, altered representation of bacterial genes and metabolic 
pathways.  Additionally, the microbiota of obese individuals harvest more energy from 
diet than non-obese individuals by extracting energy from non-digestible polysaccharides 
(Turnbaugh et al., 2009b).  An earlier study demonstrated that microbial diversity 
alterations in the Bacteriodetes and Firmicutes/Actinobacteria ratio, may depend on a 
low-calorie diet (Ley, Turnbaugh, Klein, & Gordon, 2006).  Applying this concept into 
humanized gnotobiotic mouse models transplanted with fecal microbial communities, 
Turnbaugh et al. 2009 found that switching to a “Western” diet, high in fat and sugar, 
altered the microbiome metabolic pathways and gene expression in one day (Turnbaugh 
et al., 2009a). 
Furthermore, microbiota interacts with epithelial cells to influence energy 
expenditure or storage (Tilg & Kaser, 2011; Turnbaugh et al., 2009b).  For example, the 
amount of complex carbohydrates metabolized into Short-Chain Fatty Acids (SCFA), a 
nutrition and energy source for colonocytes that maintain the integrity of gut epithelial 
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tissue, is dependent on microbial composition.   Specifically, contingent on the whether 
the predominant microbial community is co-colonized by the prominent archaeon 
Methanobrevibacter smithii and Bacteroides thetaiotaomicron, influences the efficiency 
of carbohydrate fermentation and energy absorption, resulting in overproduction of 
SCFA, and increased production of adipocytes (Samuel & Gordon, 2006).  
Furthermore, microbes affect obesity through production of signaling molecules 
that directly affect the feeling of fullness after eating, increase the storage of lipids in 
adipocytes, and decrease fatty acid oxidation in muscle tissue (Furet et al., 2010; 
Tremaroli & Backhed, 2012; Turnbaugh et al., 2006). 
  
Microbiome in the Breast Tissue  
Given the distal effect of the gut microbiome on organ systems, a new study has 
emerged examining the microbiota closer to home—looking into the colonizers of breast 
tissue.  Because microbiota exists in many different parts of the body, and have been 
consistently found in breast milk, Urbaniak et al. (2014) postulated that bacteria use the 
nipple to access the breast ducts, thus creating a breast microbiome.  The primary phylum 
of bacteria found in the breast tissue of women with or without cancer was 
Proteobacteria, followed by Firmicutes— a composition that is significantly different 
from the GI tract or other microbial colonies found in other parts of the body.  The 
authors suggest that Proteobacteria may have been selected due to their ability to 
acclimate to the high fatty acid content in the breast tissue (Urbaniak et al., 2014). Certain 
pathogenic bacteria that are able to metabolize fat such as Enterobacteriaceae, 
Psuedomonas, and Streptococcus agalactiae, were also found in the breast tissues, 
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though they have not multiplied or induced infections (Urbaniak et al., 2014).  The 
absence of infection and minimized population of these pathogenic microbes underscores 
the importance of maintaining bacterial-to-host homeostasis.  
Using next-generation sequencing, Xuan et. al. (2014) examines the dysbiosis of 
the breast microbiome by comparing the microbes present in ER+ breast tumor tissue 
with adjacent normal tissue from the same patient.  Their findings show that breast cancer 
tissue generally correlates with increased presence of Methylobacterium radiotolerans, 
and a decrease in Sphingomonas yanoikuyae numbers.  However, in normal tissue the 
inverse was true; there were more S. yanoikuyae compared to M. radiotolerans. Xuan et 
al. (2014) postulates that these two bacterial colonies balance each other’s population in 
healthy tissue.  Furthermore, a decrease in the strength of antibacterial response against 
tumor tissues was also observed as a result of decline in numbers of S. yanoikuyae, 
suggesting that this organism may have probiotic functions in the breast (Xuan et al., 
2014).  Microbial studies describe that S. yanoikuyae is a gram-negative bacteria that 
express glycosphingolipid (GSLs), compounds that activate cells that play a role in innate 
immunity such as natural killer cells (NKCs), dendritic cells and macrophages.  NKCs 
are important mediators of cancer immunosurveillance and have been reported to have an 
integral role in controlling breast cancer metastasis. For example, NKCs are involved in 
direct killing of tumors cells in culture media and in vivo models, and inhibit active 
tumor growth in mice that lack endogenous protective lymphocytes (Bassiri, Das, & 
Nichols, 2013; Kubota, Takimoto, Kaneko, Inoue, & Kumazawa, 2009; Xuan et al., 
2014).  The extent the breast microbiota help to shape the local and systemic immune 
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response, provide protective function and play a role in tumorigenesis is an area that 
needs further investigation. 
 
Bacterial Influences on Epigenetic Reprogramming of Host Cells 
 
Bacterial mechanisms that induce physiologic changes to the host signaling 
pathways, tissues, and cells also influence epigenetic processes.  Both bacteria and the 
human host are responsive to their environment through multiple pathways that impact 
the epigenome.  In bacteria, methylation of chromosomal DNA can lead to DNA 
fragmentation, recombination, translocation and can silence gene expression of a protein 
that is responsible for bacterial communication, replication, and host tissue invasion. This 
bacterial protein also contributes to anti-bacterial resistance crucial to bacterial survival 
and inter-bacterial competition.  For instance, bacterial protein expression regulated by 
DNA methylation, influences basic bacterial growth, migration and gene expression for 
protective polysaccharide production or stimulation of the host’s T-cell response 
(Zautner, 2014).  Over production of bacterial metabolic by-products can induce 
epigenetic reprogramming that affects gene expression, cancer cell viability, and 
migration and induces apoptosis or programmed cell death (Bryan et al., 2010; Kumar, 
Bryan, & Kumar, 2014; Zautner, 2014).  In terms of bacterial survival, epigenetic 
programming has also been implicated in the bacteria’s ability to resist antibiotics, as 
demonstrated by antibiotic-resistant of Streptococcus pneumoniae.   Additionally, 
lipopolysaccharides (LPS), a major component of gram-negative bacteria’s outer 
membrane, can be regulated/dysregulated at the epigenetic level, resulting in 
immunosuppression and poor disease prognosis (Angrisano et al., 2010; Zautner, 2014). 
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In higher-level eukaryotes, hotspots for methylation occur at cytosine residues 5’ 
to a guanine (CpG), as opposed to adenine and cytosine nucleotides in bacteria (Zautner, 
2014).  Epigenetic hallmarks of cancer include hypermethylation of gene-specific 
promoter and global hypomethylation of patterned/repeated sequences, which silences or 
activates pathways important in cancer development such as cell communication, tissue 
invasion/metastasis, cell cycle, DNA repair, and hormone signaling (Toland, 2012).  
Epigenetic reprogramming has been implicated in many different facets of breast cancer, 
including breast cancer subtypes.  For example, promoter-methylation of the Estrogen 
receptor alpha gene (ERα) has been noted in triple negative, basal-like breast cancer 
types associated with poor prognosis in women without family history of breast cancer 
(Jing et al., 2011).  Another area affected by epigenetic activation or silencing is the 
BRCA1 gene, which predisposes women to ovarian or breast cancer (Toland, 2012). 
The unifying theme between the epigenetic processes of bacteria and host systems 
is that bacterial influences can induce hypermethylation and epigenetic reprogramming in 
host cells that can ultimately lead to cancer.  However, in terms of direct cause of breast 
cancer, bacterial epigenetic activation that produces breast tumors remains to be 
definitely described.  Nevertheless, bacterial epigenetic reprogramming has been 
demonstrated to have a direct impact on intrauterine growth restriction after infection 
with oral bacteria Campylobacter rectus, and also directly involved in the formation of 
gastric cancer by H. Pylori (Zautner, 2014). 
 
IV-Nursing Implications:  
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Triggers that activate the cancer oncogenes may involve many systems at 
disequilibrium.  Deregulation at the epigenetic level, fueled by environmental factors and 
the activities of the microbiome can activate breast cancer development.  The risk of 
cancer can be mitigated through awareness of bacterial actions, the establishment of a 
healthy microflora, and through specific dietary choices that affect estrogenic levels, 
chronic inflammation, and obesity.  Health professionals can make lifelong positive 
impacts by promoting adoption of healthy behaviors. Encouraging new mothers to 
breastfeed establishes microbiome diversity, introduces commensal bacteria 
Bifidobacterium, guards against the risk of obesity, and stimulates the proper 
development of the immune system (Reading & Kasper, 2011; Shapira et al., 2013; 
Turroni et al., 2012).  Breastfeeding is also critical for establishing mucosal tolerance to 
immunosurveillant NKCs that is important in establishing a balanced immune system and 
in breast cancer prevention (Olszak et al., 2012).  Additionally, women with deleterious 
BRCA1 mutations, who breast-fed for a cumulative total of more than one year, have a 
statistically significant reduced risk in breast cancer compared to those who did not 
breastfeed (Kotsopoulos et al., 2012). 
Awareness of the microbiome and how dysbiosis can occur are also important 
teaching points that could help patients navigate conflicting dietary advice and promote 
adherence to dietary recommendations that decrease breast cancer risk and/or enhance 
treatment response.  Long-term dietary choices have an effect on an individual’s 
enterotypes, and the abundance of certain bacterial colonies.  Furthermore, changes in the 
microbiome are reversible through dietary choices (Zhang et al., 2012).  For example, 
numerous studies have documented how high fat and high sugar diet alters microbiota 
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composition leading to increased risks in obesity, and subsequently breast cancer 
(Carmody et al., 2015; Hildebrandt et al., 2009; Minicozzi et al., 2013; Zhang et al., 
2010).  In response to the recommendation against high sugar intake, non-caloric 
artificial sweeteners (NAS) have gained popularity as an alternative sweetener.  
However, a recently published study suggests that artificial sweetener, saccharine, may 
directly alter the microbiome, leading to dysbiosis, and subsequently to glucose 
intolerance.  Using multiple strategies, including 16rRNA analysis and metagenomic 
mapping, the study demonstrated that saccharine-fed mice, along with healthy human 
volunteers, had enhanced energy harvesting glycan-degradation pathways, associated 
with metabolic disorders and obesity (Suez et al., 2014).  Though this is the first study on 
NAS and microbiome, the epidemiological rise in obesity that coincides with the 
increased used in NAS underscores the need to correlate food production, dietary 
guidelines and nutritional recommendations to studies of the microbiome.  
Saturated fat has also been in the news recently after a meta-analysis concluded 
that the evidence of cardiovascular harm from high saturated fat intake was statistically 
not significant (Chowdhury et al., 2014).  Within the same year, a study that followed 
almost ninety thousand women over a period of 20 years, revealed that though there was 
a lack of positive association between overall total fat intake and the risk of breast cancer, 
there was evidence indicating breast cancer risk increases with early adult intake of 
animal fat (Farvid, Cho, Chen, Eliassen, & Willett, 2014).  The ongoing controversy over 
saturated fat, whether it is good or bad, adds to the plethora of confusing dietary advice.  
Accordingly, GI studies may help guide best dietary practices because they reveal that 
diets high in fat alter the microbiome diversity by decreasing the abundance of 
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Bacteriodetes, while increasing both Proteobacteria and Firmicutes, independent of 
whether or not the subjects were obese (de Wit et al., 2012; Hildebrandt et al., 2009; Wu 
et al., 2011).  
The impact of alcohol consumption on health outcomes in general is another 
important area of research.  Specific investigation into the gut microbiome of those who 
frequently consume alcohol reveal a gut flora in dysbiosis, with higher number of 
Proteobacteria and lower average abundance of Bacteroidetes, higher levels of serum 
endotoxins, as well as decreased connectivity in bacterial networks (Mutlu et al., 2012). 
Furthermore, continuing to be knowledgeable about the role of microbiome, as 
well as actions of specific bacterial communities, can shed light on how the microbiome 
enhances response to chemotherapeutic agents.   For instance, identification of chemical 
inhibitors of bacteria’s B-glucuronidase, demonstrated potential to intensify 
chemotherapeutic regimen by delaying the side-effect of diarrhea (Wallace et al., 2010).  
In terms of breast cancer treatments, methods of staging tumors are currently 
investigating not only the actual cancer cells, but also corresponding immune-balancing 
factors, based on bacterial stimulation of CD8+ effector T cells (Mlecnik, Bindea, Pages, 
& Galon, 2011).  The gut microbiome is also serving as a biomarker and therapeutic 
target for obesity through microbiome transplants (Turnbaugh, Ley, Mahowld, & 
Gordon, 2013; Turnbaugh et al., 2006).  Additionally, probiotic treatments are another 
area by which bacteria can play a protective role by excluding pathogenic colonization, 
simulating the host immune system, and enhancing mucosal barriers to invasion (Reading 
& Kasper, 2011).  Likewise, microbial secondary metabolites and bacterial mechanisms 
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have long been useful in the development of antibiotics and antitumor agents, such as 
Cisplatin  (Joyce et al. 2010; Vaishnav, 2011). The	  above	  examples	  of	  how	  the	  knowledge	  of	  the	  microbiome	  can	  and	  is	  being	  utilized	  in	  breast	  cancer	  treatments	  and	  preventative	  education	  is	  not	  comprehensive,	  but	  rather	  indicative	  of	  the	  emerging	  importance	  of	  this	  area	  of	  research	  and	  highlights	  the	  potential	  health	  gains	  that	  will	  likely	  result	  from	  further	  study	  of	  the	  microbiome	  and	  its	  systemic	  effects.	  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1—Bacterial Role in the Immune System 
Bacteria/ Bacterial Actions Immune and Cancer Effects 
Bacterial by-products of metabolism 
 
       
 
Ex: Nitric Oxide synthase 
• Stimulates increased inflammatory 
signals, such as IL-17 cytokines 
• Damages host intestinal wall;  
• Leads to dysbiosis; impaired 
homeostasis 
 
 
• Used only by pathogenic bacteria  
for rapid replication of pathogens 
 
(Sheflin et al., 2014). 
Infection by Helicobacter hepaticus in 
mouse models 
• Increased proinflammatory CD4+ 
CD45RB (hi) lymphocytes; 
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Accelerated the development of 
mammary tumors 
(Schwabe & Jobin, 2013; Rao et al.,     
2006). 
Fusobacterium nucleatum in cell culture 
studies 
• Activates apoptopic pathways; 
• Directly kill lymphocytes;  
• May promote metastasis and tumor 
growth  
 
(Shapira et al., 2013; Kaplan et al., 
2010) 
Sphingomona • Stimulates CD8+ effector T cells; 
• Improved response to adjuvant 
chemotherapy,  
• Better cancer survival rates; 
• Decreased metastasis, recurrence 
rates  
 
(Denkert et al., 2010; Shapira et al., 
2013; Mlecnik et al., 2011).  
Bacteriodes fragilis • Induces systemic T-cell regulatory 
response:  
• Improves immune defects of 
gnotobiotic mice after 
monocolonization 
 
(Ivanov et al., 2009; Reading & 
Kasper, 2011) 
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